Build your foundation. Avoid costly mistakes. Get grounded in the essentials of export controls and compliance. This session covers the key regulations, common pitfalls (including dual-use items), and why compliance matters – because mistakes can carry serious consequences. Perfect for…
CBP: Section 232 Tariffs on Auto Parts Take Effect May 3
CBP: Section 232 Tariffs on Auto Parts Take Effect May 3
CBP has announced a temporary suspension of a regulatory exception affecting certain low-value international mail shipments. Effective April 30, 2025, informal (Type 11) entries are permitted under the revised rules. Starting May 3, 2025, formal entries will be required for mail from China or Hong Kong valued over $800.
Related Posts
DoD: Evolving Priorities in Defense Contracting
The defense contracting landscape is undergoing a fundamental reset. Federal agencies are signaling a shift away from propping up contractors through guaranteed funding and extended timelines. Instead, firms are being pushed to invest their own capital, compete on merit, and deliver capabilities at wartime speed. Agility, innovation, and rapid execution are becoming decisive factors, while…
NMFS: Upcoming Import Prohibitions and Industry Webinars
The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…
CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case
Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…
USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…
